Results 31 to 40 of about 2,733 (199)

Racial and Socioeconomic Equity of Tecovirimat Treatment during the 2022 Mpox Emergency, New York, New York, USA

Emerging Infectious Diseases, 2023
We assessed tecovirimat treatment equity for 3,740 mpox patients in New York, New York, USA, during the 2022 mpox emergency; 32.4% received tecovirimat.
Maura K. Lash, Ned H. Latham, Pui Ying Chan, Mary M.K. Foote, Elizabeth A. Garcia, Matthew F. Silverstein, Marcia Wong, Mark Alexander, Karen A. Alroy, Lovedeep Bajaj, Kuan Chen, James Steele Howard, Lucretia E. Jones, Ellen H. Lee, Julian L. Watkins, Tristan D. McPherson   +15 more
doaj   +1 more source

Mpox virus infects and injures human kidney organoids, but responding to antiviral treatment [PDF]

, 2023
This work was supported by funding of a VIDI grant (91719300) from the Netherlands Organisation for Scientific Research to Q.P., and the China Scholarship Council for funding PhD fellowship to P.L.
Alam, Intikhab S., de Vries, Annemarie C., Du, Zhaoyu, Haagmans, Bart L., Hoogduijn, Martin J., Incitti, Roberto, Lamers, Mart M., Li, Pengfei, Li, Shengbing, Pan, Qiuwei, Schraauwen, Rick, Tejeda-Mora, Hector, van den Bosch, Thierry P.P.   +12 more
core   +1 more source

Mpox in persons with advanced HIV infection: a global case series [PDF]

, 2023
Background: People living with HIV have accounted for 38–50% of those affected in the 2022 multicountry mpox outbreak. Most reported cases were in people who had high CD4 cell counts and similar outcomes to those without HIV.
Alemany, A, Dunning, William, Marks, M, Mitjà, O   +3 more
core   +2 more sources

Battle won, war ongoing: A call for mpox vaccination in high-risk dermatologic cases [PDF]

JAAD Case Reports
Atika Malik, MD, Monique Kumar, MD, Tien-Anh N. Tran, MD, Timmy Do, PharmD, BCPS, BCIDP, Lindsay Lim, MD, DTMH   +4 more
doaj   +2 more sources

Efficacy of three key antiviral drugs used to treat orthopoxvirus infections: a systematic review

Global Biosecurity, 2019
Background: In a global political climate increasingly concerned about terrorism, bioterrorism agents such as smallpox would undoubtedly be catastrophic.
Joyce Yu, Suresh Mahendra Raj
doaj   +1 more source

Repositioning potentials of smallpox vaccines and antiviral agents in monkeypox outbreak: A rapid review on comparative benefits and risks

Health Science Reports, 2022
Background and aims There is a sought for vaccines and antiviral agents as countermeasures for the recent monkeypox outbreak. Here, we aimed to review and discuss the repurposing potentials of smallpox vaccines and drugs in monkeypox outbreaks based on ...
Md. Rabiul Islam, Md. Jamal Hossain, Arpita Roy, A. H. M. Nazmul Hasan, Md. Ashrafur Rahman, Mohammad Shahriar, Mohiuddin Ahmed Bhuiyan   +6 more
doaj   +1 more source

Toxicological Potential of the FDA-Approved Treatment against Monkeypox. Comment on Zovi et al. Pharmacological Agents with Antiviral Activity against Monkeypox Infection. Int. J. Mol. Sci. 2022, 23, 15941

International Journal of Translational Medicine, 2023
Recently, some drugs were approved to control Monkeypox (MPX), among them tecovirimat. This was recently approved by regulatory agencies around the world, the paper of Zovi et al entitled Pharmacological Agents with Antiviral Activity against Monkeypox ...
Gabriel Christian de Farias Morais, Umberto Laino Fulco, Edilson Dantas da Silva, Claudio Bruno Silva de Oliveira, Jonas Ivan Nobre Oliveira   +4 more
doaj   +1 more source

Monkeypox: A Contemporary Review for Healthcare Professionals [PDF]

, 2022
The ongoing 2022 multicountry outbreak of monkeypox is the largest in history to occur outside of Africa. Monkeypox is an emerging zoonotic disease that for decades has been viewed as an infectious disease with significant epidemic potential because of ...
Konomos, Michael, Kulkarni, Prathit A, Nematollahi, Saman, Tegomoh, Bryan, Titanji, Boghuma K   +4 more
core   +2 more sources

Computational Purposing Phytochemicals against Cysteine Protease of Monkeypox Virus: An In-silico Approach

Journal of Pure and Applied Microbiology, 2022
The development and evolution of viruses that cause disease have presented a formidable challenge to contemporary medicine and the global economy, not to mention a catastrophic risk to human health.
Poonam Bansal, Mahiti Gupta, Sonali Sangwan, Gurpreet Kaur Bhatia, Seema Ramniwas, Deepak Chandran, Abhijit Dey, Kuldeep Dhama, Hardeep Singh Tuli   +8 more
doaj   +1 more source

Short Note on Tecovirimat

Journal of Pharmaceutical Research International, 2021
Smallpox, an infectious disease, caused by one of the two virus variants, Variola major and Variola minor. Smallpox is a highly contagious and fatal disease. The last case which occurred naturally was in October 1977. The disease was eradicated globally by the World Health Organisation in the year 1980.
C. Sushil, S. Padmaja
openaire   +2 more sources